nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—CYP3A4—prostate cancer	0.229	1	CbGaD
Ergonovine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0624	0.112	CbGbCtD
Ergonovine—ABCB1—Estramustine—prostate cancer	0.0509	0.0915	CbGbCtD
Ergonovine—ABCB1—Cabazitaxel—prostate cancer	0.0335	0.0603	CbGbCtD
Ergonovine—CYP3A4—Bicalutamide—prostate cancer	0.0328	0.0589	CbGbCtD
Ergonovine—ABCB1—Estrone—prostate cancer	0.0328	0.0589	CbGbCtD
Ergonovine—CYP3A4—Estramustine—prostate cancer	0.0305	0.0548	CbGbCtD
Ergonovine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0292	0.0525	CbGbCtD
Ergonovine—CYP3A4—Abiraterone—prostate cancer	0.0272	0.0488	CbGbCtD
Ergonovine—CYP3A4—Flutamide—prostate cancer	0.0272	0.0488	CbGbCtD
Ergonovine—ABCB1—Conjugated Estrogens—prostate cancer	0.0215	0.0386	CbGbCtD
Ergonovine—CYP3A4—Cabazitaxel—prostate cancer	0.0201	0.0361	CbGbCtD
Ergonovine—CYP3A4—Estrone—prostate cancer	0.0196	0.0353	CbGbCtD
Ergonovine—ABCB1—Mitoxantrone—prostate cancer	0.0195	0.035	CbGbCtD
Ergonovine—ABCB1—Estradiol—prostate cancer	0.0188	0.0339	CbGbCtD
Ergonovine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0175	0.0315	CbGbCtD
Ergonovine—ABCB1—Prednisone—prostate cancer	0.0162	0.0291	CbGbCtD
Ergonovine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0129	0.0231	CbGbCtD
Ergonovine—ABCB1—Etoposide—prostate cancer	0.0123	0.0221	CbGbCtD
Ergonovine—CYP3A4—Mitoxantrone—prostate cancer	0.0117	0.021	CbGbCtD
Ergonovine—CYP3A4—Estradiol—prostate cancer	0.0113	0.0203	CbGbCtD
Ergonovine—ABCB1—Docetaxel—prostate cancer	0.0113	0.0202	CbGbCtD
Ergonovine—CYP3A4—Prednisone—prostate cancer	0.0097	0.0174	CbGbCtD
Ergonovine—ABCB1—Doxorubicin—prostate cancer	0.00839	0.0151	CbGbCtD
Ergonovine—CYP3A4—Etoposide—prostate cancer	0.00737	0.0132	CbGbCtD
Ergonovine—CYP3A4—Docetaxel—prostate cancer	0.00674	0.0121	CbGbCtD
Ergonovine—CYP3A4—Doxorubicin—prostate cancer	0.00503	0.00903	CbGbCtD
Ergonovine—Gastrointestinal pain—Estradiol valerate/Dienogest—prostate cancer	0.000573	0.00399	CcSEcCtD
Ergonovine—Myocardial infarction—Conjugated Estrogens—prostate cancer	0.00057	0.00398	CcSEcCtD
Ergonovine—Hypertension—Bicalutamide—prostate cancer	0.000569	0.00397	CcSEcCtD
Ergonovine—Sweating—Goserelin—prostate cancer	0.000563	0.00392	CcSEcCtD
Ergonovine—Chest pain—Bicalutamide—prostate cancer	0.000561	0.00392	CcSEcCtD
Ergonovine—Haematuria—Goserelin—prostate cancer	0.00056	0.0039	CcSEcCtD
Ergonovine—Dyspnoea—Cabazitaxel—prostate cancer	0.000559	0.0039	CcSEcCtD
Ergonovine—Diarrhoea—Abiraterone—prostate cancer	0.000558	0.00389	CcSEcCtD
Ergonovine—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.000554	0.00386	CcSEcCtD
Ergonovine—Gastrointestinal pain—Degarelix—prostate cancer	0.000544	0.0038	CcSEcCtD
Ergonovine—Muscle spasms—Ethinyl Estradiol—prostate cancer	0.000536	0.00374	CcSEcCtD
Ergonovine—Vomiting—Estramustine—prostate cancer	0.000534	0.00373	CcSEcCtD
Ergonovine—Dizziness—Estrone—prostate cancer	0.000531	0.0037	CcSEcCtD
Ergonovine—Shock—Bicalutamide—prostate cancer	0.000529	0.00369	CcSEcCtD
Ergonovine—Abdominal pain—Degarelix—prostate cancer	0.000526	0.00367	CcSEcCtD
Ergonovine—Headache—Estramustine—prostate cancer	0.000526	0.00367	CcSEcCtD
Ergonovine—Hyperhidrosis—Bicalutamide—prostate cancer	0.00052	0.00363	CcSEcCtD
Ergonovine—Vomiting—Abiraterone—prostate cancer	0.000519	0.00362	CcSEcCtD
Ergonovine—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.000513	0.00358	CcSEcCtD
Ergonovine—Vomiting—Estrone—prostate cancer	0.00051	0.00356	CcSEcCtD
Ergonovine—Diarrhoea—Nilutamide—prostate cancer	0.00051	0.00356	CcSEcCtD
Ergonovine—Diarrhoea—Flutamide—prostate cancer	0.000508	0.00354	CcSEcCtD
Ergonovine—Headache—Estrone—prostate cancer	0.000503	0.00351	CcSEcCtD
Ergonovine—Nausea—Estramustine—prostate cancer	0.000499	0.00348	CcSEcCtD
Ergonovine—Abdominal pain—Cabazitaxel—prostate cancer	0.000496	0.00346	CcSEcCtD
Ergonovine—Dizziness—Nilutamide—prostate cancer	0.000493	0.00344	CcSEcCtD
Ergonovine—Dizziness—Flutamide—prostate cancer	0.000491	0.00342	CcSEcCtD
Ergonovine—Ventricular arrhythmia—Epirubicin—prostate cancer	0.000488	0.00341	CcSEcCtD
Ergonovine—Dyspnoea—Bicalutamide—prostate cancer	0.00048	0.00335	CcSEcCtD
Ergonovine—Pulmonary oedema—Docetaxel—prostate cancer	0.000477	0.00333	CcSEcCtD
Ergonovine—Nausea—Estrone—prostate cancer	0.000477	0.00333	CcSEcCtD
Ergonovine—Vomiting—Nilutamide—prostate cancer	0.000474	0.00331	CcSEcCtD
Ergonovine—Vomiting—Flutamide—prostate cancer	0.000472	0.00329	CcSEcCtD
Ergonovine—Headache—Nilutamide—prostate cancer	0.000467	0.00326	CcSEcCtD
Ergonovine—Headache—Flutamide—prostate cancer	0.000465	0.00324	CcSEcCtD
Ergonovine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000463	0.00323	CcSEcCtD
Ergonovine—Acute coronary syndrome—Estradiol—prostate cancer	0.000459	0.0032	CcSEcCtD
Ergonovine—Myocardial infarction—Estradiol—prostate cancer	0.000456	0.00318	CcSEcCtD
Ergonovine—Diarrhoea—Degarelix—prostate cancer	0.000456	0.00318	CcSEcCtD
Ergonovine—Ventricular arrhythmia—Doxorubicin—prostate cancer	0.000452	0.00315	CcSEcCtD
Ergonovine—Thrombophlebitis—Docetaxel—prostate cancer	0.000449	0.00313	CcSEcCtD
Ergonovine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000445	0.00311	CcSEcCtD
Ergonovine—Haematuria—Estradiol—prostate cancer	0.000444	0.00309	CcSEcCtD
Ergonovine—Nausea—Nilutamide—prostate cancer	0.000443	0.00309	CcSEcCtD
Ergonovine—Muscle spasms—Goserelin—prostate cancer	0.000441	0.00308	CcSEcCtD
Ergonovine—Nausea—Flutamide—prostate cancer	0.000441	0.00307	CcSEcCtD
Ergonovine—Dizziness—Degarelix—prostate cancer	0.00044	0.00307	CcSEcCtD
Ergonovine—Gastrointestinal pain—Bicalutamide—prostate cancer	0.00044	0.00307	CcSEcCtD
Ergonovine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000439	0.00306	CcSEcCtD
Ergonovine—Muscle spasms—Conjugated Estrogens—prostate cancer	0.000437	0.00305	CcSEcCtD
Ergonovine—Thrombophlebitis—Capecitabine—prostate cancer	0.000435	0.00303	CcSEcCtD
Ergonovine—Diarrhoea—Cabazitaxel—prostate cancer	0.000429	0.00299	CcSEcCtD
Ergonovine—Acute coronary syndrome—Mitoxantrone—prostate cancer	0.000427	0.00298	CcSEcCtD
Ergonovine—Abdominal pain—Bicalutamide—prostate cancer	0.000425	0.00297	CcSEcCtD
Ergonovine—Myocardial infarction—Mitoxantrone—prostate cancer	0.000425	0.00296	CcSEcCtD
Ergonovine—Vomiting—Degarelix—prostate cancer	0.000423	0.00295	CcSEcCtD
Ergonovine—Headache—Degarelix—prostate cancer	0.000417	0.00291	CcSEcCtD
Ergonovine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000416	0.0029	CcSEcCtD
Ergonovine—Sweating—Mitoxantrone—prostate cancer	0.000416	0.0029	CcSEcCtD
Ergonovine—Dizziness—Cabazitaxel—prostate cancer	0.000415	0.00289	CcSEcCtD
Ergonovine—Haematuria—Mitoxantrone—prostate cancer	0.000413	0.00288	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisone—prostate cancer	0.000411	0.00287	CcSEcCtD
Ergonovine—Vertigo—Conjugated Estrogens—prostate cancer	0.000408	0.00285	CcSEcCtD
Ergonovine—Palpitations—Goserelin—prostate cancer	0.000405	0.00283	CcSEcCtD
Ergonovine—Palpitations—Conjugated Estrogens—prostate cancer	0.000401	0.0028	CcSEcCtD
Ergonovine—Vomiting—Cabazitaxel—prostate cancer	0.000399	0.00278	CcSEcCtD
Ergonovine—Bradycardia—Mitoxantrone—prostate cancer	0.000396	0.00276	CcSEcCtD
Ergonovine—Hypertension—Goserelin—prostate cancer	0.000396	0.00276	CcSEcCtD
Ergonovine—Nausea—Degarelix—prostate cancer	0.000395	0.00276	CcSEcCtD
Ergonovine—Headache—Cabazitaxel—prostate cancer	0.000393	0.00274	CcSEcCtD
Ergonovine—Chest pain—Goserelin—prostate cancer	0.00039	0.00272	CcSEcCtD
Ergonovine—Tinnitus—Estradiol—prostate cancer	0.000389	0.00272	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisone—prostate cancer	0.000387	0.0027	CcSEcCtD
Ergonovine—Chest pain—Conjugated Estrogens—prostate cancer	0.000387	0.0027	CcSEcCtD
Ergonovine—Nausea—Cabazitaxel—prostate cancer	0.000373	0.0026	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000372	0.00259	CcSEcCtD
Ergonovine—Shock—Goserelin—prostate cancer	0.000368	0.00257	CcSEcCtD
Ergonovine—Diarrhoea—Bicalutamide—prostate cancer	0.000368	0.00257	CcSEcCtD
Ergonovine—Shock—Conjugated Estrogens—prostate cancer	0.000365	0.00254	CcSEcCtD
Ergonovine—Hyperhidrosis—Goserelin—prostate cancer	0.000362	0.00252	CcSEcCtD
Ergonovine—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000359	0.00251	CcSEcCtD
Ergonovine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000358	0.0025	CcSEcCtD
Ergonovine—Dizziness—Bicalutamide—prostate cancer	0.000356	0.00248	CcSEcCtD
Ergonovine—Acute coronary syndrome—Etoposide—prostate cancer	0.000355	0.00248	CcSEcCtD
Ergonovine—Myocardial infarction—Etoposide—prostate cancer	0.000353	0.00247	CcSEcCtD
Ergonovine—Hypotension—Goserelin—prostate cancer	0.00035	0.00244	CcSEcCtD
Ergonovine—Muscle spasms—Estradiol—prostate cancer	0.00035	0.00244	CcSEcCtD
Ergonovine—Hypotension—Conjugated Estrogens—prostate cancer	0.000346	0.00242	CcSEcCtD
Ergonovine—Vomiting—Bicalutamide—prostate cancer	0.000342	0.00239	CcSEcCtD
Ergonovine—Headache—Bicalutamide—prostate cancer	0.000337	0.00235	CcSEcCtD
Ergonovine—Dyspnoea—Goserelin—prostate cancer	0.000334	0.00233	CcSEcCtD
Ergonovine—Cramps of lower extremities—Epirubicin—prostate cancer	0.000332	0.00232	CcSEcCtD
Ergonovine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000331	0.00231	CcSEcCtD
Ergonovine—Vertigo—Estradiol—prostate cancer	0.000327	0.00228	CcSEcCtD
Ergonovine—Pulmonary oedema—Epirubicin—prostate cancer	0.000322	0.00224	CcSEcCtD
Ergonovine—Palpitations—Estradiol—prostate cancer	0.000321	0.00224	CcSEcCtD
Ergonovine—Nausea—Bicalutamide—prostate cancer	0.00032	0.00223	CcSEcCtD
Ergonovine—Hypertension—Estradiol—prostate cancer	0.000314	0.00219	CcSEcCtD
Ergonovine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000311	0.00217	CcSEcCtD
Ergonovine—Chest pain—Estradiol—prostate cancer	0.000309	0.00216	CcSEcCtD
Ergonovine—Cramps of lower extremities—Doxorubicin—prostate cancer	0.000307	0.00214	CcSEcCtD
Ergonovine—Gastrointestinal pain—Goserelin—prostate cancer	0.000306	0.00214	CcSEcCtD
Ergonovine—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000303	0.00211	CcSEcCtD
Ergonovine—Thrombophlebitis—Epirubicin—prostate cancer	0.000303	0.00211	CcSEcCtD
Ergonovine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000301	0.0021	CcSEcCtD
Ergonovine—Pulmonary oedema—Doxorubicin—prostate cancer	0.000298	0.00208	CcSEcCtD
Ergonovine—Abdominal pain—Goserelin—prostate cancer	0.000296	0.00206	CcSEcCtD
Ergonovine—Acute coronary syndrome—Docetaxel—prostate cancer	0.000295	0.00206	CcSEcCtD
Ergonovine—Myocardial infarction—Docetaxel—prostate cancer	0.000294	0.00205	CcSEcCtD
Ergonovine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000293	0.00204	CcSEcCtD
Ergonovine—Hypertension—Mitoxantrone—prostate cancer	0.000292	0.00204	CcSEcCtD
Ergonovine—Shock—Estradiol—prostate cancer	0.000292	0.00204	CcSEcCtD
Ergonovine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000289	0.00202	CcSEcCtD
Ergonovine—Chest pain—Mitoxantrone—prostate cancer	0.000288	0.00201	CcSEcCtD
Ergonovine—Hyperhidrosis—Estradiol—prostate cancer	0.000287	0.002	CcSEcCtD
Ergonovine—Acute coronary syndrome—Capecitabine—prostate cancer	0.000286	0.002	CcSEcCtD
Ergonovine—Headache—Ethinyl Estradiol—prostate cancer	0.000285	0.00199	CcSEcCtD
Ergonovine—Myocardial infarction—Capecitabine—prostate cancer	0.000284	0.00198	CcSEcCtD
Ergonovine—Thrombophlebitis—Doxorubicin—prostate cancer	0.00028	0.00196	CcSEcCtD
Ergonovine—Haematuria—Capecitabine—prostate cancer	0.000277	0.00193	CcSEcCtD
Ergonovine—Shock—Mitoxantrone—prostate cancer	0.000272	0.0019	CcSEcCtD
Ergonovine—Muscle spasms—Etoposide—prostate cancer	0.000271	0.00189	CcSEcCtD
Ergonovine—Nausea—Ethinyl Estradiol—prostate cancer	0.00027	0.00188	CcSEcCtD
Ergonovine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000267	0.00186	CcSEcCtD
Ergonovine—Bradycardia—Capecitabine—prostate cancer	0.000265	0.00185	CcSEcCtD
Ergonovine—Dyspnoea—Estradiol—prostate cancer	0.000265	0.00185	CcSEcCtD
Ergonovine—Methylergometrine—CYP3A4—prostate cancer	0.000264	0.27	CrCbGaD
Ergonovine—Hypotension—Mitoxantrone—prostate cancer	0.000258	0.0018	CcSEcCtD
Ergonovine—Diarrhoea—Goserelin—prostate cancer	0.000256	0.00179	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisone—prostate cancer	0.000255	0.00178	CcSEcCtD
Ergonovine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000254	0.00177	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisone—prostate cancer	0.000253	0.00177	CcSEcCtD
Ergonovine—Vertigo—Etoposide—prostate cancer	0.000253	0.00177	CcSEcCtD
Ergonovine—Dizziness—Goserelin—prostate cancer	0.000247	0.00173	CcSEcCtD
Ergonovine—Dyspnoea—Mitoxantrone—prostate cancer	0.000246	0.00172	CcSEcCtD
Ergonovine—Dizziness—Conjugated Estrogens—prostate cancer	0.000245	0.00171	CcSEcCtD
Ergonovine—Hypertension—Etoposide—prostate cancer	0.000243	0.0017	CcSEcCtD
Ergonovine—Tinnitus—Capecitabine—prostate cancer	0.000243	0.00169	CcSEcCtD
Ergonovine—Gastrointestinal pain—Estradiol—prostate cancer	0.000243	0.00169	CcSEcCtD
Ergonovine—Chest pain—Etoposide—prostate cancer	0.00024	0.00167	CcSEcCtD
Ergonovine—Vomiting—Goserelin—prostate cancer	0.000238	0.00166	CcSEcCtD
Ergonovine—Bradycardia—Prednisone—prostate cancer	0.000236	0.00165	CcSEcCtD
Ergonovine—Vomiting—Conjugated Estrogens—prostate cancer	0.000236	0.00164	CcSEcCtD
Ergonovine—Abdominal pain—Estradiol—prostate cancer	0.000235	0.00164	CcSEcCtD
Ergonovine—Headache—Goserelin—prostate cancer	0.000234	0.00164	CcSEcCtD
Ergonovine—Headache—Conjugated Estrogens—prostate cancer	0.000232	0.00162	CcSEcCtD
Ergonovine—Hallucination—Prednisone—prostate cancer	0.000231	0.00161	CcSEcCtD
Ergonovine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000226	0.00158	CcSEcCtD
Ergonovine—Muscle spasms—Docetaxel—prostate cancer	0.000225	0.00157	CcSEcCtD
Ergonovine—Nausea—Goserelin—prostate cancer	0.000222	0.00155	CcSEcCtD
Ergonovine—Hyperhidrosis—Etoposide—prostate cancer	0.000222	0.00155	CcSEcCtD
Ergonovine—Nausea—Conjugated Estrogens—prostate cancer	0.00022	0.00154	CcSEcCtD
Ergonovine—Abdominal pain—Mitoxantrone—prostate cancer	0.000219	0.00152	CcSEcCtD
Ergonovine—Muscle spasms—Capecitabine—prostate cancer	0.000218	0.00152	CcSEcCtD
Ergonovine—Hypotension—Etoposide—prostate cancer	0.000215	0.0015	CcSEcCtD
Ergonovine—Palpitations—Docetaxel—prostate cancer	0.000207	0.00144	CcSEcCtD
Ergonovine—Dyspnoea—Etoposide—prostate cancer	0.000205	0.00143	CcSEcCtD
Ergonovine—Pergolide—CYP3A4—prostate cancer	0.000204	0.208	CrCbGaD
Ergonovine—Vertigo—Capecitabine—prostate cancer	0.000204	0.00142	CcSEcCtD
Ergonovine—Diarrhoea—Estradiol—prostate cancer	0.000203	0.00142	CcSEcCtD
Ergonovine—Hypertension—Docetaxel—prostate cancer	0.000202	0.00141	CcSEcCtD
Ergonovine—Palpitations—Capecitabine—prostate cancer	0.0002	0.0014	CcSEcCtD
Ergonovine—Chest pain—Docetaxel—prostate cancer	0.000199	0.00139	CcSEcCtD
Ergonovine—Dizziness—Estradiol—prostate cancer	0.000196	0.00137	CcSEcCtD
Ergonovine—Hypertension—Capecitabine—prostate cancer	0.000196	0.00137	CcSEcCtD
Ergonovine—Sweating—Epirubicin—prostate cancer	0.000194	0.00135	CcSEcCtD
Ergonovine—Chest pain—Capecitabine—prostate cancer	0.000193	0.00135	CcSEcCtD
Ergonovine—Haematuria—Epirubicin—prostate cancer	0.000193	0.00134	CcSEcCtD
Ergonovine—Diarrhoea—Mitoxantrone—prostate cancer	0.000189	0.00132	CcSEcCtD
Ergonovine—Vomiting—Estradiol—prostate cancer	0.000189	0.00132	CcSEcCtD
Ergonovine—Gastrointestinal pain—Etoposide—prostate cancer	0.000188	0.00131	CcSEcCtD
Ergonovine—Shock—Docetaxel—prostate cancer	0.000188	0.00131	CcSEcCtD
Ergonovine—Headache—Estradiol—prostate cancer	0.000186	0.0013	CcSEcCtD
Ergonovine—Bradycardia—Epirubicin—prostate cancer	0.000185	0.00129	CcSEcCtD
Ergonovine—Shock—Capecitabine—prostate cancer	0.000182	0.00127	CcSEcCtD
Ergonovine—Abdominal pain—Etoposide—prostate cancer	0.000182	0.00127	CcSEcCtD
Ergonovine—Vertigo—Prednisone—prostate cancer	0.000181	0.00127	CcSEcCtD
Ergonovine—Sweating—Doxorubicin—prostate cancer	0.000179	0.00125	CcSEcCtD
Ergonovine—Hyperhidrosis—Capecitabine—prostate cancer	0.000179	0.00125	CcSEcCtD
Ergonovine—Hypotension—Docetaxel—prostate cancer	0.000179	0.00125	CcSEcCtD
Ergonovine—Haematuria—Doxorubicin—prostate cancer	0.000178	0.00124	CcSEcCtD
Ergonovine—Lisuride—CYP3A4—prostate cancer	0.000177	0.181	CrCbGaD
Ergonovine—Nausea—Estradiol—prostate cancer	0.000176	0.00123	CcSEcCtD
Ergonovine—Vomiting—Mitoxantrone—prostate cancer	0.000176	0.00123	CcSEcCtD
Ergonovine—Hypertension—Prednisone—prostate cancer	0.000174	0.00122	CcSEcCtD
Ergonovine—Headache—Mitoxantrone—prostate cancer	0.000173	0.00121	CcSEcCtD
Ergonovine—Hypotension—Capecitabine—prostate cancer	0.000173	0.00121	CcSEcCtD
Ergonovine—Bradycardia—Doxorubicin—prostate cancer	0.000171	0.00119	CcSEcCtD
Ergonovine—Dyspnoea—Docetaxel—prostate cancer	0.00017	0.00119	CcSEcCtD
Ergonovine—Ergotamine—CYP3A4—prostate cancer	0.00017	0.174	CrCbGaD
Ergonovine—Tinnitus—Epirubicin—prostate cancer	0.000169	0.00118	CcSEcCtD
Ergonovine—Dyspnoea—Capecitabine—prostate cancer	0.000165	0.00115	CcSEcCtD
Ergonovine—Bromocriptine—CYP3A4—prostate cancer	0.000164	0.168	CrCbGaD
Ergonovine—Nausea—Mitoxantrone—prostate cancer	0.000164	0.00115	CcSEcCtD
Ergonovine—Shock—Prednisone—prostate cancer	0.000162	0.00113	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisone—prostate cancer	0.000159	0.00111	CcSEcCtD
Ergonovine—Diarrhoea—Etoposide—prostate cancer	0.000157	0.0011	CcSEcCtD
Ergonovine—Tinnitus—Doxorubicin—prostate cancer	0.000157	0.00109	CcSEcCtD
Ergonovine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000156	0.00109	CcSEcCtD
Ergonovine—Dizziness—Etoposide—prostate cancer	0.000152	0.00106	CcSEcCtD
Ergonovine—Muscle spasms—Epirubicin—prostate cancer	0.000152	0.00106	CcSEcCtD
Ergonovine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000151	0.00106	CcSEcCtD
Ergonovine—Abdominal pain—Docetaxel—prostate cancer	0.000151	0.00105	CcSEcCtD
Ergonovine—Abdominal pain—Capecitabine—prostate cancer	0.000146	0.00102	CcSEcCtD
Ergonovine—Vomiting—Etoposide—prostate cancer	0.000146	0.00102	CcSEcCtD
Ergonovine—Headache—Etoposide—prostate cancer	0.000144	0.00101	CcSEcCtD
Ergonovine—Vertigo—Epirubicin—prostate cancer	0.000142	0.00099	CcSEcCtD
Ergonovine—Muscle spasms—Doxorubicin—prostate cancer	0.00014	0.00098	CcSEcCtD
Ergonovine—Palpitations—Epirubicin—prostate cancer	0.00014	0.000974	CcSEcCtD
Ergonovine—Nausea—Etoposide—prostate cancer	0.000137	0.000953	CcSEcCtD
Ergonovine—Hypertension—Epirubicin—prostate cancer	0.000136	0.000951	CcSEcCtD
Ergonovine—Gastrointestinal pain—Prednisone—prostate cancer	0.000135	0.00094	CcSEcCtD
Ergonovine—Chest pain—Epirubicin—prostate cancer	0.000134	0.000938	CcSEcCtD
Ergonovine—Vertigo—Doxorubicin—prostate cancer	0.000131	0.000916	CcSEcCtD
Ergonovine—Diarrhoea—Docetaxel—prostate cancer	0.000131	0.000912	CcSEcCtD
Ergonovine—Abdominal pain—Prednisone—prostate cancer	0.00013	0.000909	CcSEcCtD
Ergonovine—Palpitations—Doxorubicin—prostate cancer	0.000129	0.000901	CcSEcCtD
Ergonovine—Shock—Epirubicin—prostate cancer	0.000127	0.000885	CcSEcCtD
Ergonovine—Diarrhoea—Capecitabine—prostate cancer	0.000127	0.000883	CcSEcCtD
Ergonovine—Dizziness—Docetaxel—prostate cancer	0.000126	0.000882	CcSEcCtD
Ergonovine—Hypertension—Doxorubicin—prostate cancer	0.000126	0.00088	CcSEcCtD
Ergonovine—Hyperhidrosis—Epirubicin—prostate cancer	0.000125	0.000869	CcSEcCtD
Ergonovine—Chest pain—Doxorubicin—prostate cancer	0.000124	0.000868	CcSEcCtD
Ergonovine—Dizziness—Capecitabine—prostate cancer	0.000122	0.000854	CcSEcCtD
Ergonovine—Vomiting—Docetaxel—prostate cancer	0.000122	0.000848	CcSEcCtD
Ergonovine—Hypotension—Epirubicin—prostate cancer	0.00012	0.00084	CcSEcCtD
Ergonovine—Headache—Docetaxel—prostate cancer	0.00012	0.000835	CcSEcCtD
Ergonovine—Vomiting—Capecitabine—prostate cancer	0.000118	0.000821	CcSEcCtD
Ergonovine—Shock—Doxorubicin—prostate cancer	0.000117	0.000819	CcSEcCtD
Ergonovine—Headache—Capecitabine—prostate cancer	0.000116	0.000809	CcSEcCtD
Ergonovine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000115	0.000804	CcSEcCtD
Ergonovine—Dyspnoea—Epirubicin—prostate cancer	0.000115	0.000802	CcSEcCtD
Ergonovine—Nausea—Docetaxel—prostate cancer	0.000114	0.000792	CcSEcCtD
Ergonovine—Diarrhoea—Prednisone—prostate cancer	0.000113	0.000787	CcSEcCtD
Ergonovine—Hypotension—Doxorubicin—prostate cancer	0.000111	0.000778	CcSEcCtD
Ergonovine—Nausea—Capecitabine—prostate cancer	0.00011	0.000767	CcSEcCtD
Ergonovine—Dizziness—Prednisone—prostate cancer	0.000109	0.00076	CcSEcCtD
Ergonovine—Dyspnoea—Doxorubicin—prostate cancer	0.000106	0.000742	CcSEcCtD
Ergonovine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000105	0.000735	CcSEcCtD
Ergonovine—Vomiting—Prednisone—prostate cancer	0.000105	0.000731	CcSEcCtD
Ergonovine—Headache—Prednisone—prostate cancer	0.000103	0.00072	CcSEcCtD
Ergonovine—Abdominal pain—Epirubicin—prostate cancer	0.000102	0.000711	CcSEcCtD
Ergonovine—Nausea—Prednisone—prostate cancer	9.79e-05	0.000683	CcSEcCtD
Ergonovine—Gastrointestinal pain—Doxorubicin—prostate cancer	9.75e-05	0.00068	CcSEcCtD
Ergonovine—Abdominal pain—Doxorubicin—prostate cancer	9.43e-05	0.000658	CcSEcCtD
Ergonovine—Diarrhoea—Epirubicin—prostate cancer	8.82e-05	0.000615	CcSEcCtD
Ergonovine—Dizziness—Epirubicin—prostate cancer	8.52e-05	0.000595	CcSEcCtD
Ergonovine—Vomiting—Epirubicin—prostate cancer	8.2e-05	0.000572	CcSEcCtD
Ergonovine—Diarrhoea—Doxorubicin—prostate cancer	8.16e-05	0.000569	CcSEcCtD
Ergonovine—Headache—Epirubicin—prostate cancer	8.08e-05	0.000563	CcSEcCtD
Ergonovine—Dizziness—Doxorubicin—prostate cancer	7.89e-05	0.00055	CcSEcCtD
Ergonovine—Nausea—Epirubicin—prostate cancer	7.66e-05	0.000534	CcSEcCtD
Ergonovine—Vomiting—Doxorubicin—prostate cancer	7.58e-05	0.000529	CcSEcCtD
Ergonovine—Headache—Doxorubicin—prostate cancer	7.47e-05	0.000521	CcSEcCtD
Ergonovine—Nausea—Doxorubicin—prostate cancer	7.08e-05	0.000494	CcSEcCtD
Ergonovine—HTR1E—Signaling Pathways—MMP9—prostate cancer	9.28e-06	0.000131	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LPL—prostate cancer	9.27e-06	0.000131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PRKACB—prostate cancer	9.26e-06	0.000131	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CDKN1A—prostate cancer	9.25e-06	0.000131	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTEN—prostate cancer	9.23e-06	0.00013	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2—prostate cancer	9.2e-06	0.00013	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF10—prostate cancer	9.18e-06	0.00013	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDGFRB—prostate cancer	9.18e-06	0.00013	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP17A1—prostate cancer	9.17e-06	0.000129	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CB—prostate cancer	9.09e-06	0.000128	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRB2—prostate cancer	9.09e-06	0.000128	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.07e-06	0.000128	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PDHA1—prostate cancer	9.05e-06	0.000128	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA3—prostate cancer	9.05e-06	0.000128	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—UCP3—prostate cancer	9.05e-06	0.000128	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TCN2—prostate cancer	9.05e-06	0.000128	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—prostate cancer	9e-06	0.000127	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—JAK2—prostate cancer	8.96e-06	0.000127	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ITGB3—prostate cancer	8.95e-06	0.000126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAP2K1—prostate cancer	8.93e-06	0.000126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CD—prostate cancer	8.87e-06	0.000125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VAV3—prostate cancer	8.86e-06	0.000125	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EP300—prostate cancer	8.8e-06	0.000124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—prostate cancer	8.74e-06	0.000123	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFBR2—prostate cancer	8.73e-06	0.000123	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NCOA2—prostate cancer	8.73e-06	0.000123	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ERBB3—prostate cancer	8.68e-06	0.000123	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGFR2—prostate cancer	8.67e-06	0.000122	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD3B1—prostate cancer	8.63e-06	0.000122	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC22A3—prostate cancer	8.63e-06	0.000122	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ITPR1—prostate cancer	8.59e-06	0.000121	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SRC—prostate cancer	8.56e-06	0.000121	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CB—prostate cancer	8.51e-06	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2—prostate cancer	8.35e-06	0.000118	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—prostate cancer	8.33e-06	0.000118	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC5A5—prostate cancer	8.33e-06	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TERT—prostate cancer	8.32e-06	0.000117	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA4—prostate cancer	8.28e-06	0.000117	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.28e-06	0.000117	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—prostate cancer	8.25e-06	0.000117	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1R—prostate cancer	8.22e-06	0.000116	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—prostate cancer	8.18e-06	0.000116	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—JAK2—prostate cancer	8.14e-06	0.000115	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP2E1—prostate cancer	8.14e-06	0.000115	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA2—prostate cancer	8.06e-06	0.000114	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NQO1—prostate cancer	8.05e-06	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SULT1A1—prostate cancer	7.97e-06	0.000112	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG5—prostate cancer	7.97e-06	0.000112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HIF1A—prostate cancer	7.96e-06	0.000112	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TH—prostate cancer	7.93e-06	0.000112	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LPL—prostate cancer	7.88e-06	0.000111	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP3A4—prostate cancer	7.85e-06	0.000111	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2—prostate cancer	7.82e-06	0.00011	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFRB—prostate cancer	7.81e-06	0.00011	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA1—prostate cancer	7.78e-06	0.00011	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—prostate cancer	7.77e-06	0.00011	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CB—prostate cancer	7.73e-06	0.000109	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1B1—prostate cancer	7.71e-06	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CAV1—prostate cancer	7.7e-06	0.000109	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD3B2—prostate cancer	7.69e-06	0.000109	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTO1—prostate cancer	7.69e-06	0.000109	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NAT2—prostate cancer	7.69e-06	0.000109	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—prostate cancer	7.67e-06	0.000108	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—prostate cancer	7.65e-06	0.000108	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ITGB3—prostate cancer	7.61e-06	0.000107	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KDR—prostate cancer	7.61e-06	0.000107	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGFR—prostate cancer	7.5e-06	0.000106	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GGT1—prostate cancer	7.47e-06	0.000105	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—prostate cancer	7.43e-06	0.000105	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ESR1—prostate cancer	7.42e-06	0.000105	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB3—prostate cancer	7.38e-06	0.000104	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLCB2—prostate cancer	7.38e-06	0.000104	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LRP2—prostate cancer	7.38e-06	0.000104	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.38e-06	0.000104	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGFR2—prostate cancer	7.37e-06	0.000104	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NCOA1—prostate cancer	7.36e-06	0.000104	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP19A1—prostate cancer	7.25e-06	0.000102	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—BAD—prostate cancer	7.24e-06	0.000102	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—P4HB—prostate cancer	7.23e-06	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2—prostate cancer	7.1e-06	0.0001	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KRAS—prostate cancer	7.08e-06	0.0001	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TERT—prostate cancer	7.07e-06	9.99e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.04e-06	9.94e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CG—prostate cancer	7.01e-06	9.9e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APC—prostate cancer	7.01e-06	9.9e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—RXRA—prostate cancer	7e-06	9.88e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGF—prostate cancer	6.93e-06	9.78e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS1—prostate cancer	6.93e-06	9.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SULT2A1—prostate cancer	6.86e-06	9.68e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HIF1A—prostate cancer	6.77e-06	9.55e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MED12—prostate cancer	6.75e-06	9.53e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—COMT—prostate cancer	6.74e-06	9.52e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GSK3B—prostate cancer	6.73e-06	9.5e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTP1—prostate cancer	6.71e-06	9.48e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GNG5—prostate cancer	6.69e-06	9.45e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—INS—prostate cancer	6.64e-06	9.37e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—prostate cancer	6.6e-06	9.32e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ITPR1—prostate cancer	6.6e-06	9.32e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CAV1—prostate cancer	6.54e-06	9.24e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CA—prostate cancer	6.51e-06	9.19e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CREBBP—prostate cancer	6.5e-06	9.18e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KDR—prostate cancer	6.47e-06	9.13e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA3—prostate cancer	6.45e-06	9.1e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—prostate cancer	6.42e-06	9.06e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EGFR—prostate cancer	6.39e-06	9.02e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ESR1—prostate cancer	6.31e-06	8.9e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TP53—prostate cancer	6.3e-06	8.89e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TYMS—prostate cancer	6.24e-06	8.81e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAP2K1—prostate cancer	6.2e-06	8.76e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—prostate cancer	6.17e-06	8.71e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CD—prostate cancer	6.16e-06	8.7e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—BAD—prostate cancer	6.15e-06	8.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HPGDS—prostate cancer	6.15e-06	8.68e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.11e-06	8.63e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CA—prostate cancer	6.1e-06	8.62e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—prostate cancer	6.09e-06	8.61e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LPL—prostate cancer	6.05e-06	8.55e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—KRAS—prostate cancer	6.03e-06	8.52e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTT1—prostate cancer	5.97e-06	8.42e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ACHE—prostate cancer	5.97e-06	8.42e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APC—prostate cancer	5.96e-06	8.42e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CG—prostate cancer	5.96e-06	8.42e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF2—prostate cancer	5.9e-06	8.33e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.9e-06	8.33e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS1—prostate cancer	5.89e-06	8.32e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGF—prostate cancer	5.89e-06	8.32e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1A1—prostate cancer	5.85e-06	8.26e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOS3—prostate cancer	5.82e-06	8.22e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ERCC2—prostate cancer	5.8e-06	8.19e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—prostate cancer	5.76e-06	8.14e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.74e-06	8.1e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GSK3B—prostate cancer	5.72e-06	8.08e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PRKACB—prostate cancer	5.71e-06	8.06e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAK2—prostate cancer	5.66e-06	7.98e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.65e-06	7.97e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—INS—prostate cancer	5.64e-06	7.97e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CA—prostate cancer	5.54e-06	7.83e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CREBBP—prostate cancer	5.53e-06	7.8e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MDM2—prostate cancer	5.52e-06	7.79e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—prostate cancer	5.46e-06	7.7e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—prostate cancer	5.45e-06	7.7e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ERBB2—prostate cancer	5.44e-06	7.68e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EGFR—prostate cancer	5.43e-06	7.67e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA2—prostate cancer	5.38e-06	7.6e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CB—prostate cancer	5.37e-06	7.58e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARA—prostate cancer	5.35e-06	7.55e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—prostate cancer	5.32e-06	7.51e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAP2K1—prostate cancer	5.27e-06	7.45e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CD—prostate cancer	5.24e-06	7.4e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CA—prostate cancer	5.19e-06	7.33e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	5.18e-06	7.32e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—prostate cancer	5.16e-06	7.29e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.13e-06	7.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	5.13e-06	7.24e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1B—prostate cancer	5.04e-06	7.12e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CAV1—prostate cancer	5.03e-06	7.1e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF2—prostate cancer	5.02e-06	7.08e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.01e-06	7.08e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—prostate cancer	4.99e-06	7.04e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NQO1—prostate cancer	4.96e-06	7e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOS3—prostate cancer	4.95e-06	6.99e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—prostate cancer	4.94e-06	6.97e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2—prostate cancer	4.93e-06	6.96e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—prostate cancer	4.91e-06	6.93e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TH—prostate cancer	4.89e-06	6.9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAK2—prostate cancer	4.81e-06	6.79e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCND1—prostate cancer	4.81e-06	6.79e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CTNNB1—prostate cancer	4.76e-06	6.72e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.75e-06	6.71e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	4.71e-06	6.65e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MDM2—prostate cancer	4.69e-06	6.63e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—prostate cancer	4.67e-06	6.59e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	4.65e-06	6.57e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTEN—prostate cancer	4.64e-06	6.55e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	4.63e-06	6.53e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GGT1—prostate cancer	4.6e-06	6.5e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CG—prostate cancer	4.58e-06	6.47e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	4.57e-06	6.45e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA1—prostate cancer	4.53e-06	6.4e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—prostate cancer	4.53e-06	6.39e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.47e-06	6.31e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EP300—prostate cancer	4.43e-06	6.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	4.39e-06	6.2e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—INS—prostate cancer	4.34e-06	6.12e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—RXRA—prostate cancer	4.31e-06	6.09e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SRC—prostate cancer	4.3e-06	6.08e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	4.29e-06	6.05e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CREBBP—prostate cancer	4.25e-06	5.99e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	4.24e-06	5.99e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	4.2e-06	5.93e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2—prostate cancer	4.19e-06	5.92e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	4.19e-06	5.92e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	4.17e-06	5.89e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—COMT—prostate cancer	4.15e-06	5.87e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—prostate cancer	4.15e-06	5.86e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTP1—prostate cancer	4.13e-06	5.84e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	4.09e-06	5.77e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ITPR1—prostate cancer	4.07e-06	5.74e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	4.05e-06	5.72e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CD—prostate cancer	4.03e-06	5.68e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	3.97e-06	5.6e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	3.96e-06	5.58e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	3.95e-06	5.57e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—prostate cancer	3.86e-06	5.45e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	3.85e-06	5.44e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	3.85e-06	5.43e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TYMS—prostate cancer	3.84e-06	5.43e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NOS3—prostate cancer	3.8e-06	5.37e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—prostate cancer	3.8e-06	5.37e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGFR—prostate cancer	3.77e-06	5.33e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EP300—prostate cancer	3.76e-06	5.31e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPL—prostate cancer	3.73e-06	5.27e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SRC—prostate cancer	3.66e-06	5.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.6e-06	5.09e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ERCC2—prostate cancer	3.57e-06	5.04e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	3.56e-06	5.03e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KRAS—prostate cancer	3.56e-06	5.03e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	3.53e-06	4.98e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CB—prostate cancer	3.51e-06	4.95e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—prostate cancer	3.48e-06	4.91e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—prostate cancer	3.36e-06	4.74e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARA—prostate cancer	3.29e-06	4.65e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—prostate cancer	3.28e-06	4.63e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	3.27e-06	4.62e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	3.27e-06	4.62e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	3.21e-06	4.53e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TP53—prostate cancer	3.17e-06	4.47e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CAV1—prostate cancer	3.1e-06	4.37e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTEN—prostate cancer	3.03e-06	4.28e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	3.03e-06	4.28e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—prostate cancer	2.9e-06	4.09e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—EP300—prostate cancer	2.89e-06	4.08e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.82e-06	3.98e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	2.78e-06	3.93e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TP53—prostate cancer	2.69e-06	3.8e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—prostate cancer	2.67e-06	3.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—INS—prostate cancer	2.67e-06	3.77e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CREBBP—prostate cancer	2.62e-06	3.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.48e-06	3.5e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—prostate cancer	2.47e-06	3.48e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NOS3—prostate cancer	2.34e-06	3.31e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	2.27e-06	3.21e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.16e-06	3.05e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.14e-06	3.02e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CA—prostate cancer	2.14e-06	3.02e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTEN—prostate cancer	1.87e-06	2.64e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—EP300—prostate cancer	1.78e-06	2.52e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—prostate cancer	1.75e-06	2.47e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.32e-06	1.86e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—prostate cancer	1.08e-06	1.52e-05	CbGpPWpGaD
